Fumi Kikuchi

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto’s disease and diabetes mellitus: a case report

Kazuko Yonezaki, Toshihiro Kobayashi, Hitomi Imachi et al. · Journal of Medical Case Reports · 2018 · 33 citations · Full text

Life Sciences, Endocrinology, Oncology +17

Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese Type 2-diabetic patients on hemodialysis

Masanori Abe, Fumi Kikuchi, K Kaizu et al. · Clinical Nephrology · 2007 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +17